Avalon Trust Co cut its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 94.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 113 shares of the healthcare conglomerate’s stock after selling 2,111 shares during the quarter. Avalon Trust Co’s holdings in UnitedHealth Group were worth $35,000 at the end of the most recent quarter.
Several other hedge funds also recently bought and sold shares of UNH. Good Life Advisors LLC grew its holdings in shares of UnitedHealth Group by 396.7% in the 2nd quarter. Good Life Advisors LLC now owns 4,883 shares of the healthcare conglomerate’s stock valued at $1,524,000 after buying an additional 3,900 shares during the period. ABN Amro Investment Solutions acquired a new position in UnitedHealth Group in the second quarter valued at about $10,362,000. Cherokee Insurance Co acquired a new stake in shares of UnitedHealth Group during the second quarter worth about $1,809,000. Police & Firemen s Retirement System of New Jersey grew its position in shares of UnitedHealth Group by 3.2% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 138,189 shares of the healthcare conglomerate’s stock valued at $43,111,000 after purchasing an additional 4,254 shares during the period. Finally, Geode Capital Management LLC raised its holdings in UnitedHealth Group by 3.3% during the 2nd quarter. Geode Capital Management LLC now owns 21,312,182 shares of the healthcare conglomerate’s stock worth $6,624,411,000 after buying an additional 675,075 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
UNH has been the topic of a number of research analyst reports. Sanford C. Bernstein raised their price objective on shares of UnitedHealth Group from $433.00 to $440.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Weiss Ratings upgraded UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, October 24th. KeyCorp lifted their target price on UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research report on Wednesday, October 8th. Royal Bank Of Canada raised their price target on shares of UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. Finally, TD Cowen increased their target price on shares of UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a report on Thursday, October 30th. Eighteen equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $397.12.
UnitedHealth Group Price Performance
NYSE:UNH opened at $332.53 on Friday. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The firm has a fifty day simple moving average of $347.53 and a 200 day simple moving average of $320.74. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $622.83. The stock has a market capitalization of $301.22 billion, a PE ratio of 17.36, a P/E/G ratio of 2.28 and a beta of 0.47.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. During the same quarter last year, the firm posted $7.15 EPS. The company’s quarterly revenue was up 12.2% on a year-over-year basis. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.7%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s payout ratio is currently 46.14%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- What is a Microcap Stock? Everything You Need to Know
- dLocal Falls Despite Blowout Q3 Results—What Investors Are Missing
- Trading Stocks: RSI and Why it’s Useful
- Ondas Holdings Signals a Rebound as Drone Demand Soars
- Expert Stock Trading Psychology Tips
- Disney’s 2026 Outlook Brightens Under Iger’s Magic Touch
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
